Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 13 July 1990:
Vol. 249. no. 4965, pp. 146 - 151
DOI: 10.1126/science.2371562
Prev | Table of Contents | Next

Articles

Science, Vol 249, Issue 4965, 146-151
Copyright © 1990 by American Association for the Advancement of Science

articles

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

HF Weisman, T Bartow, MK Leppo, HC Marsh Jr, GR Carson, MF Concino, MP Boyle, KH Roux, ML Weisfeldt, and DT Fearon

Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.

The complement system is an important mediator of the acute inflammatory response, and an effective inhibitor would suppress tissue damage in many autoimmune and inflammatory diseases. Such an inhibitor might be found among the endogenous regulatory proteins of complement that block the enzymes that activate C3 and C5. Of these proteins, complement receptor type 1 (CR1; CD35) has the most inhibitory potential, but its restriction to a few cell types limits its function in vivo. This limitation was overcome by the recombinant, soluble human CR1, sCR1, which lacks the transmembrane and cytoplasmic domains. The sCR1 bivalently bound dimeric forms of its ligands, C3b and methylamine-treated C4 (C4-ma), and promoted their inactivation by factor I. In nanomolar concentrations, sCR1 blocked complement activation in human serum by the two pathways. The sCR1 had complement inhibitory and anti-inflammatory activities in a rat model of reperfusion injury of ischemic myocardium, reducing myocardial infarction size by 44 percent. These findings identify sCR1 as a potential agent for the suppression of complement-dependent tissue injury in autoimmune and inflammatory diseases.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Comparative Functional Evolution of Human and Mouse CR1 and CR2.
A. C. Jacobson and J. H. Weis (2008)
J. Immunol. 181, 2953-2959
   Full Text »    PDF »
Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction.
M. Salio, S. Chimenti, N. De Angelis, F. Molla, V. Maina, M. Nebuloni, F. Pasqualini, R. Latini, C. Garlanda, and A. Mantovani (2008)
Circulation 117, 1055-1064
   Abstract »    Full Text »    PDF »
Myeloperoxidase Is Critically Involved in the Induction of Organ Damage after Renal Ischemia Reperfusion.
R. A. Matthijsen, D. Huugen, N. T. Hoebers, B. de Vries, C. J. Peutz-Kootstra, Y. Aratani, M. R. Daha, J. W. C. Tervaert, W. A. Buurman, and P. Heeringa (2007)
Am. J. Pathol. 171, 1743-1752
   Abstract »    Full Text »    PDF »
Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1.
Y. Banz, O. M. Hess, S. C. Robson, E. Csizmadia, D. Mettler, P. Meier, A. Haeberli, S. Shaw, R. A. Smith, and R. Rieben (2007)
Cardiovasc Res 76, 482-493
   Abstract »    Full Text »    PDF »
Complement Dependent Amplification of the Innate Response to a Cognate Microbial Ligand by the Long Pentraxin PTX3.
A. Cotena, V. Maina, M. Sironi, B. Bottazzi, P. Jeannin, A. Vecchi, N. Corvaia, M. R. Daha, A. Mantovani, and C. Garlanda (2007)
J. Immunol. 179, 6311-6317
   Abstract »    Full Text »    PDF »
Beneficial Effects of Complement Inhibition With Soluble Complement Receptor 1 (TP10) During Cardiac Surgery: Is There a Gender Difference?.
H. L. Lazar, T. Keilani, C. A. Fitzgerald, O. M. Shapira, C. T. Hunter, R. J. Shemin, H. C. Marsh Jr, U. S. Ryan, and the TP10 Cardiac Surgery Study Group (2007)
Circulation 116, I-83-I-88
   Abstract »    Full Text »    PDF »
The Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight.
M. M. Markiewski and J. D. Lambris (2007)
Am. J. Pathol. 171, 715-727
   Abstract »    Full Text »    PDF »
Epstein-Barr Virus Entry.
L. M. Hutt-Fletcher (2007)
J. Virol. 81, 7825-7832
   Full Text »    PDF »
A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritis.
K. J. Katschke Jr., K. Y. Helmy, M. Steffek, H. Xi, J. Yin, W. P. Lee, P. Gribling, K. H. Barck, R. A.D. Carano, R. E. Taylor, et al. (2007)
J. Exp. Med. 204, 1319-1325
   Abstract »    Full Text »    PDF »
Innate response to self-antigen significantly exacerbates burn wound depth.
F. Suber, M. C. Carroll, and F. D. Moore Jr. (2007)
PNAS 104, 3973-3977
   Abstract »    Full Text »    PDF »
Interaction of complement and leukocytes in severe acute pancreatitis: potential for therapeutic intervention..
W. Hartwig, M. Klafs, M. Kirschfink, T. Hackert, L. Schneider, M.-M. Gebhard, M. W. Buchler, and J. Werner (2006)
Am J Physiol Gastrointest Liver Physiol 291, G844-G850
   Abstract »    Full Text »    PDF »
Therapeutic Strategy with a Membrane-Localizing Complement Regulator to Increase the Number of Usable Donor Organs after Prolonged Cold Storage.
H. Patel, R. A.G. Smith, S. H. Sacks, and W. Zhou (2006)
J. Am. Soc. Nephrol. 17, 1102-1111
   Abstract »    Full Text »    PDF »
Local extravascular pool of C3 is a determinant of postischemic acute renal failure.
C. A. Farrar, W. Zhou, T. Lin, and S. H. Sacks (2006)
FASEB J 20, 217-226
   Abstract »    Full Text »    PDF »
Estrogens and Glucocorticoids Have Opposing Effects on the Amount and Latent Activity of Complement Proteins in the Rat Uterus.
T. Rhen and J. A. Cidlowski (2006)
Biol Reprod 74, 265-274
   Abstract »    Full Text »    PDF »
Identification of the target self-antigens in reperfusion injury.
M. Zhang, E. M. Alicot, I. Chiu, J. Li, N. Verna, T. Vorup-Jensen, B. Kessler, M. Shimaoka, R. Chan, D. Friend, et al. (2006)
J. Exp. Med. 203, 141-152
   Abstract »    Full Text »    PDF »
Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury.
Y. Banz, O. M. Hess, S. C. Robson, D. Mettler, P. Meier, A. Haeberli, E. Csizmadia, E. Y. Korchagina, N. V. Bovin, and R. Rieben (2005)
Eur. Heart J. 26, 2334-2343
   Abstract »    Full Text »    PDF »
Synergy between Two Active Sites of Human Complement Receptor Type 1 (CD35) in Complement Regulation: Implications for the Structure of the Classical Pathway C3 Convertase and Generation of More Potent Inhibitors.
M. Krych-Goldberg, R. E. Hauhart, T. Porzukowiak, and J. P. Atkinson (2005)
J. Immunol. 175, 4528-4535
   Abstract »    Full Text »    PDF »
Inflammatory response post-myocardial infarction and reperfusion: a new therapeutic target?.
R. F. Bonvini, T. Hendiri, and E. Camenzind (2005)
Eur. Heart J. Suppl. 7, I27-I36
   Abstract »    Full Text »    PDF »
Activated human PMN synthesize and release a strongly fucosylated glycoform of {alpha}1-acid glycoprotein, which is transiently deposited in human myocardial infarction.
D. C. W. Poland, J.-J. G. Vallejo, H. W. M. Niessen, R. Nijmeyer, J. Calafat, C. E. Hack, B. Van het Hof, and W. Van Dijk (2005)
J. Leukoc. Biol. 78, 453-461
   Abstract »    Full Text »    PDF »
Mannose-Binding Lectin Is a Regulator of Inflammation That Accompanies Myocardial Ischemia and Reperfusion Injury.
M. C. Walsh, T. Bourcier, K. Takahashi, L. Shi, M. N. Busche, R. P. Rother, S. D. Solomon, R. A. B. Ezekowitz, and G. L. Stahl (2005)
J. Immunol. 175, 541-546
   Abstract »    Full Text »    PDF »
Inaugural Article: Biography of Douglas T. Fearon.
R. Nuzzo (2005)
PNAS 102, 7415-7417
   Full Text »    PDF »
IgM colocalises with complement and C reactive protein in infarcted human myocardium.
P A J Krijnen, C Ciurana, T Cramer, T Hazes, C J L M Meijer, C A Visser, H W M Niessen, and C E Hack (2005)
J. Clin. Pathol. 58, 382-388
   Abstract »    Full Text »    PDF »
Chronic Treatment With Allopurinol Boosts Survival and Cardiac Contractility in Murine Postischemic Cardiomyopathy.
L. B. Stull, M. K. Leppo, L. Szweda, W. D. Gao, and E. Marban (2004)
Circ. Res. 95, 1005-1011
   Abstract »    Full Text »    PDF »
Complement Inactivation by Recombinant Human C3 Derivatives.
J. Kolln, E. Spillner, J. Andra, K. Klensang, and R. Bredehorst (2004)
J. Immunol. 173, 5540-5545
   Abstract »    Full Text »    PDF »
Vascular ischaemia and reperfusion injury.
H. K. Eltzschig and C. D. Collard (2004)
Br. Med. Bull. 70, 71-86
   Abstract »    Full Text »    PDF »
Production of a complement inhibitor possessing sialyl Lewis X moieties by in vitro glycosylation technology.
L. J. Thomas, K. Panneerselvam, D. T. Beattie, M. D. Picard, B. Xu, C. W. Rittershaus, H. C. Marsh Jr., R. A. Hammond, J. Qian, T. Stevenson, et al. (2004)
Glycobiology 14, 883-893
   Abstract »    Full Text »    PDF »
Soluble Human Complement Receptor 1 Limits Ischemic Damage in Cardiac Surgery Patients at High Risk Requiring Cardiopulmonary Bypass.
H. L. Lazar, P. M. Bokesch, F. van Lenta, C. Fitzgerald, C. Emmett, H. C. Marsh Jr, U. Ryan, and OBE and the TP10 Cardiac Surgery Study Group (2004)
Circulation 110, II-274-II-279
   Abstract »    Full Text »    PDF »
CD59a Deficiency Exacerbates Ischemia-Reperfusion Injury in Mice.
D. Turnberg, M. Botto, M. Lewis, W. Zhou, S. H. Sacks, B. P. Morgan, M. J. Walport, and H. T. Cook (2004)
Am. J. Pathol. 165, 825-832
   Abstract »    Full Text »    PDF »
Reduced erythrocyte complement receptor type 1 in systemic lupus erythematosus is related to a disease activity index and not to the presence or severity of renal disease.
C E de Carvalho Lins, L S P. Crott, J E Teixeira, and J E Barbosa (2004)
Lupus 13, 517-521
   Abstract »    PDF »
Backbone dynamics of complement control protein (CCP) modules reveals mobility in binding surfaces.
J. M. O'Leary, K. Bromek, G. M. Black, S. Uhrinova, C. Schmitz, X. Wang, M. Krych, J. P. Atkinson, D. Uhrin, and P. N. Barlow (2004)
Protein Sci. 13, 1238-1250
   Abstract »    Full Text »    PDF »
Soluble complement receptor 1 preserves endothelial barrier function and microcirculation in postischemic pancreatitis in the rat.
E. von Dobschuetz, O. Bleiziffer, S. Pahernik, M. Dellian, T. Hoffmann, and K. Messmer (2004)
Am J Physiol Gastrointest Liver Physiol 286, G791-G796
   Abstract »    Full Text »    PDF »
Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury.
M. Zhang, W. G. Austen Jr., I. Chiu, E. M. Alicot, R. Hung, M. Ma, N. Verna, M. Xu, H. B. Hechtman, F. D. Moore Jr., et al. (2004)
PNAS 101, 3886-3891
   Abstract »    Full Text »    PDF »
Streptococcal M5 Protein Prevents Neutrophil Phagocytosis by Interfering with CD11b/CD18 Receptor-Mediated Association and Signaling.
M. Weineisen, U. Sjobring, M. Fallman, and T. Andersson (2004)
J. Immunol. 172, 3798-3807
   Abstract »    Full Text »    PDF »
Pathways to Acute Humoral Rejection.
S. Saadi, T. Takahashi, R. A. Holzknecht, and J. L. Platt (2004)
Am. J. Pathol. 164, 1073-1080
   Abstract »    Full Text »    PDF »
Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice.
J.-i. Oyama, C. Blais Jr, X. Liu, M. Pu, L. Kobzik, R. A. Kelly, and T. Bourcier (2004)
Circulation 109, 784-789
   Abstract »    Full Text »    PDF »
The C4A and C4B Isotypic Forms of Human Complement Fragment C4b Have the Same Intrinsic Affinity for Complement Receptor 1 (CR1/CD35).
L. Clemenza and D. E. Isenman (2004)
J. Immunol. 172, 1670-1680
   Abstract »    Full Text »    PDF »
From The Cover: A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria.
I. A. Cockburn, M. J. Mackinnon, A. O'Donnell, S. J. Allen, J. M. Moulds, M. Baisor, M. Bockarie, J. C. Reeder, and J. A. Rowe (2004)
PNAS 101, 272-277
   Abstract »    Full Text »    PDF »
Inhibition of Complement Activation Decreases Airway Inflammation and Hyperresponsiveness.
C. Taube, Y.-H. Rha, K. Takeda, J.-W. Park, A. Joetham, A. Balhorn, A. Dakhama, P. C. Giclas, V. M. Holers, and E. W. Gelfand (2003)
Am. J. Respir. Crit. Care Med. 168, 1333-1341
   Abstract »    Full Text »    PDF »
C-reactive protein and cardiovascular disease: new insights from an old molecule.
G.M. Hirschfield and M.B. Pepys (2003)
QJM 96, 793-807
   Abstract »    Full Text »    PDF »
Complement and the Kidney.
R. J. Quigg (2003)
J. Immunol. 171, 3319-3324
   Full Text »    PDF »
Nontransgenic Hyperexpression of a Complement Regulator in Donor Kidney Modulates Transplant Ischemia/Reperfusion Damage, Acute Rejection, and Chronic Nephropathy.
J. R. Pratt, M. E. Jones, J. Dong, W. Zhou, P. Chowdhury, R. A. G. Smith, and S. H. Sacks (2003)
Am. J. Pathol. 163, 1457-1465
   Abstract »    Full Text »    PDF »
Microvascular Inflammatory Response in Cardiac Surgery.
A. J. Chong, C. R. Hampton, and E. D. Verrier (2003)
Seminars in Cardiothoracic and Vascular Anesthesia 7, 333-354
   Abstract »    PDF »
Mechanism of Complement Activation and Its Role in the Inflammatory Response After Thoracoabdominal Aortic Aneurysm Repair.
A. E. Fiane, V. Videm, P. S. Lingaas, L. Heggelund, E. W. Nielsen, O. R. Geiran, M. Fung, and T. E. Mollnes (2003)
Circulation 108, 849-856
   Abstract »    Full Text »    PDF »
Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy.
K. Yazdanbakhsh, S. Kang, D. Tamasauskas, D. Sung, and A. Scaradavou (2003)
Blood 101, 5046-5052
   Abstract »    Full Text »    PDF »
A Peptide Derived from the Parasite Receptor, Complement C2 Receptor Inhibitor Trispanning, Suppresses Immune Complex-Mediated Inflammation in Mice.
J. M. Inal, B. Schneider, M. Armanini, and J. A. Schifferli (2003)
J. Immunol. 170, 4310-4317
   Abstract »    Full Text »    PDF »
Complement Factor C5a Mediates Renal Ischemia-Reperfusion Injury Independent from Neutrophils.
B. de Vries, J. Kohl, W. K. G. Leclercq, T. G. A. M. Wolfs, A. A. J. H. M. van Bijnen, P. Heeringa, and W. A. Buurman (2003)
J. Immunol. 170, 3883-3889
   Abstract »    Full Text »    PDF »
Administration of a Soluble Recombinant Complement C3 Inhibitor Protects Against Renal Disease in MRL/lpr Mice.
L. Bao, M. Haas, D. M. Kraus, B. K. Hack, J. K. Rakstang, V. M. Holers, and R. J. Quigg (2003)
J. Am. Soc. Nephrol. 14, 670-679
   Abstract »    Full Text »    PDF »
Complement in Ischemia Reperfusion Injury.
N. C. Riedemann and P. A. Ward (2003)
Am. J. Pathol. 162, 363-367
   Full Text »    PDF »
Role for the Alternative Complement Pathway in Ischemia/Reperfusion Injury.
G. L. Stahl, Y. Xu, L. Hao, M. Miller, J. A. Buras, M. Fung, and H. Zhao (2003)
Am. J. Pathol. 162, 449-455
   Abstract »    Full Text »    PDF »
Lack of a Functional Alternative Complement Pathway Ameliorates Ischemic Acute Renal Failure in Mice.
J. M. Thurman, D. Ljubanovic, C. L. Edelstein, G. S. Gilkeson, and V. M. Holers (2003)
J. Immunol. 170, 1517-1523
   Abstract »    Full Text »    PDF »
Functional Activity of Natural Antibody is Altered in Cr2-Deficient Mice.
R. R. Reid, S. Woodcock, A. Shimabukuro-Vornhagen, W. G. Austen Jr., L. Kobzik, M. Zhang, H. B. Hechtman, F. D. Moore Jr., and M. C. Carroll (2002)
J. Immunol. 169, 5433-5440
   Abstract »    Full Text »    PDF »
Cutting Edge: Localization of the Host Recognition Functions of Complement Factor H at the Carboxyl-Terminal: Implications for Hemolytic Uremic Syndrome.
M. K. Pangburn (2002)
J. Immunol. 169, 4702-4706
   Abstract »    Full Text »    PDF »
sCR1sLeX reduces lung allograft ischemia-reperfusion injury but does not ameliorate acute rejection.
U. Stammberger, J. Hamacher, J.-C. Pache, and R. A. Schmid (2002)
Eur. J. Cardiothorac. Surg. 22, 368-372
   Abstract »    Full Text »    PDF »
Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.
T. E. Mollnes, O.-L. Brekke, M. Fung, H. Fure, D. Christiansen, G. Bergseth, V. Videm, K. T. Lappegard, J. Kohl, and J. D. Lambris (2002)
Blood 100, 1869-1877
   Abstract »    Full Text »    PDF »
Cardiomyopathy Is Linked to Complement Activation.
M. Afanasyeva and N. R. Rose (2002)
Am. J. Pathol. 161, 351-357
   Full Text »    PDF »
From the Cover: Variola virus immune evasion design: Expression of a highly efficient inhibitor of human complement.
A. M. Rosengard, Y. Liu, Z. Nie, and R. Jimenez (2002)
PNAS 99, 8808-8813
   Abstract »    Full Text »    PDF »
Transgenic Expression of a Soluble Complement Inhibitor Protects Against Renal Disease and Promotes Survival in MRL/lpr Mice.
L. Bao, M. Haas, S. A. Boackle, D. M. Kraus, P. N. Cunningham, P. Park, J. J. Alexander, R. K. Anderson, K. Culhane, V. M. Holers, et al. (2002)
J. Immunol. 168, 3601-3607
   Abstract »    Full Text »    PDF »
Novel Small Molecule Inhibitor of C1s Exerts Cardioprotective Effects in Ischemia-Reperfusion Injury in Rabbits.
M. Buerke, H. Schwertz, W. Seitz, J. Meyer, and H. Darius (2001)
J. Immunol. 167, 5375-5380
   Abstract »    Full Text »    PDF »
Contribution of Anaphylatoxin C5a to Late Airway Responses After Repeated Exposure of Antigen to Allergic Rats.
M. Abe, K. Shibata, H. Akatsu, N. Shimizu, N. Sakata, T. Katsuragi, and H. Okada (2001)
J. Immunol. 167, 4651-4660
   Abstract »    Full Text »    PDF »
Complement Activation in Patients With Congestive Heart Failure: Effect of High-Dose Intravenous Immunoglobulin Treatment.
P. Aukrust, L. Gullestad, K. T. Lappegard, T. Ueland, H. Aass, L. Wikeby, S. Simonsen, S. S. Froland, and T. E. Mollnes (2001)
Circulation 104, 1494-1500
   Abstract »    Full Text »    PDF »
Inhibition of Mannose-Binding Lectin Reduces Postischemic Myocardial Reperfusion Injury.
J. E. Jordan, M. C. Montalto, and G. L. Stahl (2001)
Circulation 104, 1413-1418
   Abstract »    Full Text »    PDF »
Endothelial Oxidative Stress Activates the Lectin Complement Pathway : Role of Cytokeratin 1.
C. D. Collard, M. C. Montalto, W. R. Reenstra, J. A. Buras, and G. L. Stahl (2001)
Am. J. Pathol. 159, 1045-1054
   Abstract »    Full Text »    PDF »
Serum Proteins Modified by Neutrophil-Derived Oxidants as Mediators of Neutrophil Stimulation.
G. F. Kormoczi, U. M. Wolfel, A. R. Rosenkranz, W. H. Horl, R. Oberbauer, and G. J. Zlabinger (2001)
J. Immunol. 167, 451-460
   Abstract »    Full Text »    PDF »
Inhibiting the Complement System Does Not Reduce Injury in Renal Ischemia Reperfusion.
P. PARK, M. HAAS, P. N. CUNNINGHAM, J. J. ALEXANDER, L. BAO, J. M. GUTHRIDGE, D. M. KRAUS, V. M. HOLERS, and R. J. QUIGG (2001)
J. Am. Soc. Nephrol. 12, 1383-1390
   Abstract »    Full Text »    PDF »
Kupffer cell-initiated remote hepatic injury following bilateral hindlimb ischemia is complement dependent.
R. W. Brock, R. G. Nie, K. A. Harris, and R. F. Potter (2001)
Am J Physiol Gastrointest Liver Physiol 280, G279-G284
   Abstract »    Full Text »    PDF »
Ulex europaeus agglutinin II (UEA-II) is a novel, potent inhibitor of complement activation.
R. Lekowski, C. D. Collard, W. R. Reenstra, and G. L. Stahl (2001)
Protein Sci. 10, 277-284
   Abstract »    Full Text »
Leukocyte filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury.
G Matheis, M Scholz, J Gerber, U Abdel-Rahman, G Wimmer-Greinecker, and A Moritz (2001)
Perfusion 16, 43-49
   Abstract »    PDF »
Expression of a Soluble Complement Inhibitor Protects Transgenic Mice from Antibody-Induced Acute Renal Failure.
B. SCHILLER, P. N. CUNNINGHAM, J. J. ALEXANDER, L. BAO, V. M. HOLERS, and R. J. QUIGG (2001)
J. Am. Soc. Nephrol. 12, 71-79
   Abstract »    Full Text »
Physiologic and Immunologic Hurdles to Xenotransplantation.
B. SAMSTEIN and J. L. PLATT (2001)
J. Am. Soc. Nephrol. 12, 182-193
   Abstract »    Full Text »
sCR1sLeX ameliorates ischemia/reperfusion injury in experimental lung transplantation.
U. Stammberger, J. Hamacher, S. Hillinger, and R. A. Schmid (2000)
J. Thorac. Cardiovasc. Surg. 120, 1078-1084
   Abstract »    Full Text »    PDF »
Mapping of the Region of Complement Receptor (CR) 1 Required for Plasmodium falciparum Rosetting and Demonstration of the Importance of CR1 in Rosetting in Field Isolates.
J. A. Rowe, S. J. Rogerson, A. Raza, J. M. Moulds, M. D. Kazatchkine, K. Marsh, C. I. Newbold, J. P. Atkinson, and L. H. Miller (2000)
J. Immunol. 165, 6341-6346
   Abstract »    Full Text »    PDF »
Binding Kinetics, Structure-Activity Relationship, and Biotransformation of the Complement Inhibitor Compstatin.
A. Sahu, A. M. Soulika, D. Morikis, L. Spruce, W. T. Moore, and J. D. Lambris (2000)
J. Immunol. 165, 2491-2499
   Abstract »    Full Text »    PDF »
PTX3, A Prototypical Long Pentraxin, Is an Early Indicator of Acute Myocardial Infarction in Humans.
G. Peri, M. Introna, D. Corradi, G. Iacuitti, S. Signorini, F. Avanzini, F. Pizzetti, A. P. Maggioni, T. Moccetti, M. Metra, et al. (2000)
Circulation 102, 636-641
   Abstract »    Full Text »    PDF »
Isolation, Characterization, and Cloning of Porcine Complement Component C7.
A. Agah, M. C. Montalto, C. L. Kiesecker, M. Morrissey, M. Grover, K. L. Whoolery, R. P. Rother, and G. L. Stahl (2000)
J. Immunol. 165, 1059-1065
   Abstract »    Full Text »    PDF »
A New Small Molecule C5a Receptor Antagonist Inhibits the Reverse-Passive Arthus Reaction and Endotoxic Shock in Rats.
A. J. Strachan, T. M. Woodruff, G. Haaima, D. P. Fairlie, and S. M. Taylor (2000)
J. Immunol. 164, 6560-6565
   Abstract »    Full Text »    PDF »
Lipoteichoic Acid Induces Delayed Protection in the Rat Heart : A Comparison With Endotoxin.
K. Zacharowski, S. Frank, M. Otto, P. K. Chatterjee, S. Cuzzocrea, G. Hafner, J. Pfeilschifter, and C. Thiemermann (2000)
Arterioscler. Thromb. Vasc. Biol. 20, 1521-1528
   Abstract »    Full Text »    PDF »
Complement Activation Promotes Muscle Inflammation during Modified Muscle Use.
J. Frenette, B. Cai, and J. G. Tidball (2000)
Am. J. Pathol. 156, 2103-2110
   Abstract »    Full Text »    PDF »
cAMP Pulse During Preservation Inhibits the Late Development of Cardiac Isograft and Allograft Vasculopathy.
C. Y. Wang, I. Aronson, S. Takuma, S. Homma, Y. Naka, T. Alshafie, V. Brovkovych, T. Malinski, M. C. Oz, and D. J. Pinsky (2000)
Circ. Res. 86, 982-988
   Abstract »    Full Text »    PDF »
Molecular Mechanisms of Target Recognition in an Innate Immune System: Interactions Among Factor H, C3b, and Target in the Alternative Pathway of Human Complement ,2.
M. K. Pangburn, K. L. W. Pangburn, V. Koistinen, S. Meri, and A. K. Sharma (2000)
J. Immunol. 164, 4742-4751
   Abstract »    Full Text »    PDF »
Complement Activation after Oxidative Stress : Role of the Lectin Complement Pathway.
C. D. Collard, A. Vakeva, M. A. Morrissey, A. Agah, S. A. Rollins, W. R. Reenstra, J. A. Buras, S. Meri, and G. L. Stahl (2000)
Am. J. Pathol. 156, 1549-1556
   Abstract »    Full Text »    PDF »
Blockade of Complement Inhibits Obliterative Bronchiolitis in Rat Tracheal Allografts.
E. A. KALLIO, K. B. LEMSTRÖM, P. J. HÄYRY, U. S. RYAN, and P. K. KOSKINEN (2000)
Am. J. Respir. Crit. Care Med. 161, 1332-1339
   Abstract »    Full Text »
Complement Activation Products in the Urine from Proteinuric Patients.
Y. MORITA, H. IKEGUCHI, J. NAKAMURA, N. HOTTA, Y. YUZAWA, and S. MATSUO (2000)
J. Am. Soc. Nephrol. 11, 700-707
   Abstract »    Full Text »    PDF »
Mesenteric dysfunction after cardiopulmonary bypass: role of complement C5a.
M. Tofukuji, G. L. Stahl, C. Metais, M. Tomita, A. Agah, C. Bianchi, M. P. Fink, and F. W. Sellke (2000)
Ann. Thorac. Surg. 69, 799-807
   Abstract »    Full Text »    PDF »
C1-Esterase Inhibitor: An Anti-Inflammatory Agent and Its Potential Use in the Treatment of Diseases Other Than Hereditary Angioedema.
C. Caliezi, W. A. Wuillemin, S. Zeerleder, M. Redondo, B. Eisele, and C. E. Hack (2000)
Pharmacol. Rev. 52, 91-112
   Abstract »    Full Text »    PDF »
Soluble Complement Receptor-1 Protects Heart, Lung, and Cardiac Myofilament Function From Cardiopulmonary Bypass Damage.
P. J. Chai, R. Nassar, A. E. Oakeley, D. M. Craig, G. Quick Jr, J. Jaggers, S. P. Sanders, R. M. Ungerleider, and P. A. W. Anderson (2000)
Circulation 101, 541-546
   Abstract »